| Sepedeh Nabavi, MD | |
|
1412 Milstead Ave Ne, Conyers, GA 30012-3877 | |
| (770) 597-3081 | |
| Not Available |
| Full Name | Sepedeh Nabavi |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 1412 Milstead Ave Ne, Conyers, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699119206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 77087 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northside Emergency Associates, P.c. | 9335135144 | 29 |
| Manning Emergency Medical Associates Pllc | 0244397271 | 18 |
News Archive
Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease.
Hearing loss affects approximately 48 million Americans. Some evidence suggests that diet may influence risk of hearing loss. Previous studies have looked at how specific nutrients affect risk, but the relation of overall diet and risk of developing hearing loss was unclear.
Preliminary research indicates that several specific genetic alterations are associated with the development of smoking-related head and neck skin cancers, according to a report in the January 10 issue of JAMA: The Journal of the American Medical Association.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
› Verified 9 days ago
| Entity Name | Emerginet, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164480869 PECOS PAC ID: 4082515853 Enrollment ID: O20040115000322 |
News Archive
Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease.
Hearing loss affects approximately 48 million Americans. Some evidence suggests that diet may influence risk of hearing loss. Previous studies have looked at how specific nutrients affect risk, but the relation of overall diet and risk of developing hearing loss was unclear.
Preliminary research indicates that several specific genetic alterations are associated with the development of smoking-related head and neck skin cancers, according to a report in the January 10 issue of JAMA: The Journal of the American Medical Association.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
› Verified 9 days ago
| Entity Name | Northside Emergency Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285686303 PECOS PAC ID: 9335135144 Enrollment ID: O20040426000165 |
News Archive
Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease.
Hearing loss affects approximately 48 million Americans. Some evidence suggests that diet may influence risk of hearing loss. Previous studies have looked at how specific nutrients affect risk, but the relation of overall diet and risk of developing hearing loss was unclear.
Preliminary research indicates that several specific genetic alterations are associated with the development of smoking-related head and neck skin cancers, according to a report in the January 10 issue of JAMA: The Journal of the American Medical Association.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
› Verified 9 days ago
| Entity Name | Gwinnett Emergency Specialists Observation Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720373129 PECOS PAC ID: 7618140955 Enrollment ID: O20111101000364 |
News Archive
Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease.
Hearing loss affects approximately 48 million Americans. Some evidence suggests that diet may influence risk of hearing loss. Previous studies have looked at how specific nutrients affect risk, but the relation of overall diet and risk of developing hearing loss was unclear.
Preliminary research indicates that several specific genetic alterations are associated with the development of smoking-related head and neck skin cancers, according to a report in the January 10 issue of JAMA: The Journal of the American Medical Association.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sepedeh Nabavi, MD 180 Shoreline Walk, Alpharetta, GA 30022-7638 Ph: (770) 597-3081 | Sepedeh Nabavi, MD 1412 Milstead Ave Ne, Conyers, GA 30012-3877 Ph: (770) 597-3081 |
News Archive
Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease.
Hearing loss affects approximately 48 million Americans. Some evidence suggests that diet may influence risk of hearing loss. Previous studies have looked at how specific nutrients affect risk, but the relation of overall diet and risk of developing hearing loss was unclear.
Preliminary research indicates that several specific genetic alterations are associated with the development of smoking-related head and neck skin cancers, according to a report in the January 10 issue of JAMA: The Journal of the American Medical Association.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
› Verified 9 days ago
Angela Feazel Mattke, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1412 Milstead Ave Ne, Conyers, GA 30012 Phone: 770-994-9326 Fax: 770-994-4747 | |
Jorge E Rivera-kolb, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1008 Meadow Springs Dr Sw, Conyers, GA 30094 Phone: 770-648-6207 | |
John Tucker Irwin, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Stillmeadow Rd Sw, Conyers, GA 30094 Phone: 770-827-9526 | |
Dr. Ellica Moore Chu, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1412 Milstead Ave Ne, Conyers, GA 30012 Phone: 770-918-3000 Fax: 404-809-4284 | |
Dr. Keith Howell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1412 Milstead Avenue, Conyers, GA 30012 Phone: 770-994-9326 Fax: 770-994-4747 | |
Dr. Melissa Evans Jordan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1412 Milstead Ave Ne, Conyers, GA 30012 Phone: 770-994-9426 |